Proton Pump Inhibitors and Risk of Infection: Is Suppression of Immune Defence Molecules to Blame?
Author:
Abstract
Funder
This article is published under the Creative Commons Attribution Non-commercial License.
Publisher
Touch Medical Media, Ltd.
Subject
General Earth and Planetary Sciences
Reference30 articles.
1. Ghebre YT, Raghu G. Idiopathic pulmonary fibrosis: novel concepts of proton pump inhibitors as antifibrotic drugs.Am J Respir Crit Care Med. 2016;193:1345–52.
2. Yu LY, Sun LN, Zhang XH, et al. A review of the novel application and potential adverse effects of proton pump inhibitors.Adv Ther. 2017;34:1070–86.
3. Singh A, Cresci GA, Kirby DF. Proton pump inhibitors: risks and rewards and emerging consequences to the gut microbiome.Nutr Clin Pract. 2018;33:614–24.
4. Meijvis SC, Cornips MC, Voorn GP, et al. Microbial evaluation of proton-pump inhibitors and the risk of pneumonia.Eur Respir J. 2011;38:1165–72.
5. Lazaro-Pacheco IB, Servin-Caamano AI, Perez-Hernandez JL, et al. Proton pump inhibitors increase the overall risk of developing bacterial infections in patients with cirrhosis.Arq Gastroenterol. 2018;55:28–32.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3